Abstract

BackgroundPostauricular injection as a local therapy has been confirmed to be effective for inner ear diseases. However, the mechanism for the drugs entering the inner ears remains unknown. This study aims to compare the distribution of dexamethasone by intramuscular injection with that by postauricular injection, and explore the pathway of the drugs entering the inner ears.MethodsAn in vivo optical imaging system was used to conduct a time course observation to compare the distribution of dexamethasone by intramuscular injection with that by postauricular injection in male guinea pigs. The drug availability in the tympanic mucosa, tympanum, endolymphatic sac, and cochlea was observed by a confocal laser scanning microscope.ResultsThe local fluorescent intensity by postauricular injection was significantly higher in the inner ears, and lower in partial peripheral organs, than that by the intramuscular injection. The drug metabolism by postauricular injection exhibited an obviously sustained release effect in the inner ears. Drugs by postauricular injection might enter the endolymphatic sac through the posterior auricular artery and occipital artery, as well as the connections of the mastoid emissary vein, sigmoid sinus and endolymphatic sac.ConclusionMore drugs concentrated in the inner ear for longer therapeutic time and less systemic delivery implied more effective and less risk of side effects through postauricular injection than intramuscular injection safer for the treatment of inner ear diseases.

Highlights

  • IntroductionEspecially sensorineural hearing loss (SSNHL), are common diseases in clinical practice

  • Inner ear disorders, especially sensorineural hearing loss (SSNHL), are common diseases in clinical practice

  • The fluorescence in the postauricular injection group decreased at a slower pace than that in the intramuscular injection group

Read more

Summary

Introduction

Especially sensorineural hearing loss (SSNHL), are common diseases in clinical practice. Local drug delivery to the inner ear via intratympanic injection was firstly described for the treatment of Ménière’s disease in 1956 [4], and it was reported that intratympanic injection of methylprednisolone could significantly improve the hearing of patients with SSNHL [5]. Intracochlear delivery has been a hot topic as it provides direct access to cochlear cells and the drug dosage can be precisely controlled. This innovative method may cause greater risks of surgical trauma and biofouling for indwelling devices, as a result of tissue growth and protein build-up in the scala tympani [7]. This study aims to compare the distribution of dexamethasone by intramuscular injection with that by postauricular injection, and explore the pathway of the drugs entering the inner ears

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call